Is it best to obtain informed consent from schizophrenic patients about the possible risk of drug treatment, for example, tardive dyskinesia, before initiating treatment or at a later date?
D014150:Antipsychotic Agents / Q000009:adverse effects*; D032882:Comprehension; D030881:Disclosure; D006801:Humans; D007258:Informed Consent; D028642:Persons with Psychiatric Disorders; D018570:Risk Assessment; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents